CN102228643A - Traditional Chinese medicine composition for treating chronic prostatitis - Google Patents
Traditional Chinese medicine composition for treating chronic prostatitis Download PDFInfo
- Publication number
- CN102228643A CN102228643A CN2011101969362A CN201110196936A CN102228643A CN 102228643 A CN102228643 A CN 102228643A CN 2011101969362 A CN2011101969362 A CN 2011101969362A CN 201110196936 A CN201110196936 A CN 201110196936A CN 102228643 A CN102228643 A CN 102228643A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- herba
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating chronic prostatitis, belonging to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared from the following medicinal raw materials in parts by weight: 15-25 parts of longhairy antenoron herb, 15-25 parts of dandelion, 5-15 parts of cowherb seed, 5-15 parts of herba pyrrosiae, 5-15 parts of bamboo leaf, 5-15 parts of kuh-seng, 15-25 parts of chlorhexidine, 15-25 parts of oldenlandia diffusa, 15-25 parts of red peony root, 15-25 parts of rehmannia root, 15-25 parts of oxalis, 5-15 parts of rhubarb, 15-25 parts of giant knotweed, 5-15 parts of root-bark of tree peony, 5-12 parts of cinnamon, 5-15 parts of oriental waterplantain rhizome, 15-25 parts of coix seed and 5-10 parts of licorice. The traditional Chinese medicine composition for treating chronic prostatitis can quickly play the effects on promoting blood circulation by removing blood stasis, clearing away heat, promoting diuresis, diminishing inflammation, alleviating pain, treating stranguria and promoting urination, thus achieving the aims of killing pathogenic bacteria and diminishing inflammation, and the total effective rate is 95%.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of chronic prostatitis, belong to technical field of Chinese medicines.
Background technology
Chronic prostatitis is between twenty and fifty man's commonly encountered diseases, a frequently-occurring disease, and sickness rate accounts for about 40%.The symptom of common chronic prostatitis has urethra scorching hot, hypogastric region and perineal position swelling and pain, frequent micturition, urgent micturition, waist soreness etc.Have patients with chronic prostatitis more than half after an action of the bowels adularescent mucus overflow from urethra, underwear often has stain etc., reproduction age, the man can cause infertility.Chronic prostatitis belongs to categories such as " nebulousurine ", " smart turbid " in Chinese medicine.The traditional Chinese medical science thinks that this disease is owing to " damp-heat in lower-JIAO ", " gasification imbalance " institute cause.Though people are aspect treatment chronic prostate medicament selection, Chinese medicine is best first-selected,, still there is not specific medicament for the treatment chronic prostatitis in the prior art, the curative effect of its medicine has much room for improvement.
Summary of the invention
Purpose of the present invention is exactly that a kind of Chinese medicine composition with treatment chronic prostatitis of better curative effect will be provided.
The present invention is achieved in that by following bulk drugs and forms have better curative effect: 15-25 parts of Herba Lysimachiaes, 15-25 parts of Herba Taraxacis, 5-15 parts of SEMEN VACCARIAE, 5-15 parts of Folium Pyrrosiae, 5-15 parts on Folium Bambusae, 5-15 parts of Radix Sophorae Flavescentiss, 15-25 parts of BITAI, 15-25 parts of Herba Hedyotidis Diffusae, 15-25 parts of Radix Paeoniae Rubra, 15-25 parts in the Radix Rehmanniae, 15-25 parts of Herba Patriniae, 5-15 parts of Radix Et Rhizoma Rhei, 15-25 parts of Rhizoma Polygoni Cuspidati, 5-15 parts of Cortex Moutans, 5-12 parts of Cortex Cinnamomis, 5-15 parts of Rhizoma Alismatis, 15-25 parts of Semen Coicis, 5-10 parts in Radix Glycyrrhizae.
When this Chinese medicine composition was decocted in water for oral dose, every part was adopted gram to be unit, every day potion, decocting divides secondary oral, 7 days is a course of treatment, reaches rehabilitation effect 1 ~ 3 course of treatment substantially, again 1 ~ 2 course of treatment of after treatment, can reach the clinical cure effect.
Preparation technology of the present invention meets new Chinese medicine preparation technology's specification requirement in principle, uses modern preparation new technique, becomes various decoctions, oral liquid or electuary etc. with the crude drug combined preparation.By doctor's advice oral after, effective ingredient in the crude drug can quick penetration prostate film, gets the effect of blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis, anti-inflammatory analgetic, diuresis promoting rapidly, reaches the therapeutic purposes that degerm is eliminated inflammation.
The specific embodiment
The present invention is described further by clinical observation and embodiment.
The clinical observation on the therapeutic effect data.
1, clinical physical data: receive smelting patient 100 examples altogether, wherein the age: 12 examples below 30 years old, 30 ~ 35 years old 23 example, 35 ~ 45 years old 36 example, 29 examples more than 45 years old; The oldest 70 years old, minimum 25 years old of age; Unmarried 32 examples, married 68 examples.
2, diagnostic criteria.
(1), clinically mainly show as: frequent micturition, urgent micturition, dysurea, paruria, it is scratchy that the urine meaning reaches urethra not to the utmost; After an action of the bowels droplet satellite, drip whitely, urethral orifice has haircuts, liquid, there is the pain of degree not at the anus position and weighs down the sense of expanding, testis distending pain, pudendum distending pain, waist are ached etc.; Sexual impotence, premature ejaculation are waited until sexual dysfunction.
(2), examination of prostatic fluid, lecithin reduces, leukocyte greater than 10 or pus cell "+" above/every high power field.
3, Therapeutic Method: according to prostatitic etiology and pathogenesis, with the present invention is base side, and prescription adjusts accordingly in following scope endogenous cause of ill symptom: 15-25 parts of Herba Lysimachiaes, 15-25 parts of Herba Taraxacis, 5-15 parts of SEMEN VACCARIAE, 5-15 parts of Folium Pyrrosiae, 5-15 parts on Folium Bambusae, 5-15 parts of Radix Sophorae Flavescentiss, 15-25 parts of BITAI, 15-25 parts of Herba Hedyotidis Diffusae, 15-25 parts of Radix Paeoniae Rubra, 15-25 parts in the Radix Rehmanniae, 15-25 parts of Herba Patriniae, 5-15 parts of Radix Et Rhizoma Rhei, 15-25 parts of Rhizoma Polygoni Cuspidati, 5-15 parts of Cortex Moutans, 5-12 parts of Cortex Cinnamomis, 5-15 parts of Rhizoma Alismatis, 15-25 parts of Semen Coicis, 5-10 parts in Radix Glycyrrhizae.
The crude drug compositions is obtained decoction by traditional middle drug-decocting method.Oral, about 264 grams of primary material drug composition consumption, one day secondary (look the state of an illness, follow the doctor's advice), 7 days is a course of treatment, reaches rehabilitation effect 1 ~ 3 course of treatment substantially, again 1 ~ 2 course of treatment of after treatment, can reach the clinical cure effect.
4, efficacy assessment standard.
Recovery from illness: clinical symptom disappearance, under every high power field, leukocyte is lower than below 10, and it is normal that lecithin recovers.
Produce effects: clinical symptoms alleviates substantially or obviously, and gland liquid is conventional near normal, and prostate does not have obvious tenderness.
Take a turn for the better: subjective symptoms disappear or significantly alleviate, no tenderness, the more preceding obvious minimizing of the conventional leukocyte number of gland liquid, lecithin increase or normal substantially.
Invalid: 3 of medications are more than the course of treatment, and symptom does not have obvious improvement; Each index does not have obvious change.
5, therapeutic outcome.
By the conventional therapy of 1 ~ 3 course of treatment, can improve clinical symptoms rapidly: recovery from illness: 35 examples; Produce effects: 21 examples; Take a turn for the better: 25 examples; Invalid: 19 examples; Total effective rate 81%.
Through 1 ~ 2 after treatment course of treatment, clinical symptoms rapidly disappears, body constitution recovers normal again; Recovery from illness: 40 examples; Produce effects 32 examples; 23 examples take a turn for the better; Invalid 5 examples; Total effective rate 95%.
The present invention can specifically implement by the technology contents that illustrates in the summary of the invention, can further describe the present invention by the following examples, yet scope of the present invention is not limited to following embodiment.
Embodiment 1: it is made up of following bulk drugs: 20 parts of Herba Lysimachiaes, 20 parts of Herba Taraxacis, 10 parts of SEMEN VACCARIAE, 10 parts of Folium Pyrrosiae, 10 parts on Folium Bambusae, 10 parts of Radix Sophorae Flavescentiss, 20 parts of BITAI, 20 parts of Herba Hedyotidis Diffusae, 20 parts of Radix Paeoniae Rubra, 20 parts in the Radix Rehmanniae, 20 parts of Herba Patriniae, 10 parts of Radix Et Rhizoma Rhei, 20 parts of Rhizoma Polygoni Cuspidati, 10 parts of Cortex Moutans, 8 parts of Cortex Cinnamomis, 10 parts of Rhizoma Alismatis, 20 parts of Semen Coicis, 6 parts in Radix Glycyrrhizae.
Embodiment 2: it is made up of following bulk drugs: 15 parts of Herba Lysimachiaes, 25 parts of Herba Taraxacis, 5 parts of SEMEN VACCARIAE, 15 parts of Folium Pyrrosiae, 5 parts on Folium Bambusae, 15 parts of Radix Sophorae Flavescentiss, 15 parts of BITAI, 25 parts of Herba Hedyotidis Diffusae, 15 parts of Radix Paeoniae Rubra, 25 parts in the Radix Rehmanniae, 15 parts of Herba Patriniae, 15 parts of Radix Et Rhizoma Rhei, 15 parts of Rhizoma Polygoni Cuspidati, 15 parts of Cortex Moutans, 5 parts of Cortex Cinnamomis, 15 parts of Rhizoma Alismatis, 15 parts of Semen Coicis, 10 parts in Radix Glycyrrhizae.
Embodiment 3: it is made up of following bulk drugs: 25 parts of Herba Lysimachiaes, 15 parts of Herba Taraxacis, 15 parts of SEMEN VACCARIAE, 5 parts of Folium Pyrrosiae, 15 parts on Folium Bambusae, 5 parts of Radix Sophorae Flavescentiss, 25 parts of BITAI, 15 parts of Herba Hedyotidis Diffusae, 25 parts of Radix Paeoniae Rubra, 15 parts in the Radix Rehmanniae, 25 parts of Herba Patriniae, 5 parts of Radix Et Rhizoma Rhei, 25 parts of Rhizoma Polygoni Cuspidati, 5 parts of Cortex Moutans, 12 parts of Cortex Cinnamomis, 5 parts of Rhizoma Alismatis, 25 parts of Semen Coicis, 5 parts in Radix Glycyrrhizae.
Embodiment 4: it is made up of following bulk drugs: 18 parts of Herba Lysimachiaes, 22 parts of Herba Taraxacis, 12 parts of SEMEN VACCARIAE, 8 parts of Folium Pyrrosiae, 12 parts on Folium Bambusae, 12 parts of Radix Sophorae Flavescentiss, 18 parts of BITAI, 18 parts of Herba Hedyotidis Diffusae, 22 parts of Radix Paeoniae Rubra, 22 parts in the Radix Rehmanniae, 18 parts of Herba Patriniae, 8 parts of Radix Et Rhizoma Rhei, 22 parts of Rhizoma Polygoni Cuspidati, 12 parts of Cortex Moutans, 10 parts of Cortex Cinnamomis, 8 parts of Rhizoma Alismatis, 22 parts of Semen Coicis, 8 parts in Radix Glycyrrhizae.
Claims (2)
1. Chinese medicine composition for the treatment of chronic prostatitis, it is characterized in that it is made up of following bulk drugs: 15-25 parts of Herba Lysimachiaes, 15-25 parts of Herba Taraxacis, 5-15 parts of SEMEN VACCARIAE, 5-15 parts of Folium Pyrrosiae, 5-15 parts on Folium Bambusae, 5-15 parts of Radix Sophorae Flavescentiss, 15-25 parts of BITAI, 15-25 parts of Herba Hedyotidis Diffusae, 15-25 parts of Radix Paeoniae Rubra, 15-25 parts in the Radix Rehmanniae, 15-25 parts of Herba Patriniae, 5-15 parts of Radix Et Rhizoma Rhei, 15-25 parts of Rhizoma Polygoni Cuspidati, 5-15 parts of Cortex Moutans, 5-12 parts of Cortex Cinnamomis, 5-15 parts of Rhizoma Alismatis, 15-25 parts of Semen Coicis, 5-10 parts in Radix Glycyrrhizae.
2. a kind of Chinese medicine composition for the treatment of chronic prostatitis according to claim 1 is characterized in that it is made up of following bulk drugs: 20 parts of Herba Lysimachiaes, 20 parts of Herba Taraxacis, 10 parts of SEMEN VACCARIAE, 10 parts of Folium Pyrrosiae, 10 parts on Folium Bambusae, 10 parts of Radix Sophorae Flavescentiss, 20 parts of BITAI, 20 parts of Herba Hedyotidis Diffusae, 20 parts of Radix Paeoniae Rubra, 20 parts in the Radix Rehmanniae, 20 parts of Herba Patriniae, 10 parts of Radix Et Rhizoma Rhei, 20 parts of Rhizoma Polygoni Cuspidati, 10 parts of Cortex Moutans, 8 parts of Cortex Cinnamomis, 10 parts of Rhizoma Alismatis, 20 parts of Semen Coicis, 6 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101969362A CN102228643A (en) | 2011-07-14 | 2011-07-14 | Traditional Chinese medicine composition for treating chronic prostatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101969362A CN102228643A (en) | 2011-07-14 | 2011-07-14 | Traditional Chinese medicine composition for treating chronic prostatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102228643A true CN102228643A (en) | 2011-11-02 |
Family
ID=44841275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101969362A Pending CN102228643A (en) | 2011-07-14 | 2011-07-14 | Traditional Chinese medicine composition for treating chronic prostatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102228643A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755534A (en) * | 2012-03-26 | 2012-10-31 | 赵冲祥 | Health care herbal medicine for treating prostatitis |
| CN102872338A (en) * | 2012-09-18 | 2013-01-16 | 刘玉才 | Traditional Chinese medicine preparation for treating chronic prostatitis |
-
2011
- 2011-07-14 CN CN2011101969362A patent/CN102228643A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755534A (en) * | 2012-03-26 | 2012-10-31 | 赵冲祥 | Health care herbal medicine for treating prostatitis |
| CN102755534B (en) * | 2012-03-26 | 2014-01-01 | 赵冲祥 | Health care herbal medicine for treating prostatitis |
| CN102872338A (en) * | 2012-09-18 | 2013-01-16 | 刘玉才 | Traditional Chinese medicine preparation for treating chronic prostatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101912593B (en) | Medicament for treating dysmenorrheal and preparation method thereof | |
| CN102228603B (en) | Chinese medicine for treating retention of urine | |
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN102284050B (en) | Chinese medicine composition for treating infertility caused by cold uterus | |
| CN102940853A (en) | Navel paste for treating mammary gland hyperplasia diseases | |
| CN101716298B (en) | Traditional Chinese medicine preparation for treating surgical intestinal adhesions | |
| CN101869665A (en) | Chinese medicinal composition for treating necrospermia, asthenospermia oligospermia, or aspermatism | |
| CN101361877B (en) | External washing lotion for treating gynaecologic inflammation | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN102335367B (en) | Medicine for treating pelvic inflammation | |
| CN102872408A (en) | Chinese medicinal preparation treating dysmenorrhea | |
| CN102228643A (en) | Traditional Chinese medicine composition for treating chronic prostatitis | |
| CN102600351B (en) | Traditional Chinese medicine for treating pruritus cutanea | |
| CN100540030C (en) | A kind of topical agent for the treatment of dysmenorrhes | |
| CN103301305A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
| CN103768478A (en) | Traditional Chinese medicine composition for treating prostatitis and preparation method and application thereof | |
| CN105770748A (en) | Traditional Chinese medicine composition for treating gouts | |
| CN102743686B (en) | The scorching clearing capsule of a kind of basin | |
| CN102872416B (en) | Traditional Chinese medicine sitting lotion for treating chronic prostatitis | |
| CN102349949B (en) | Traditional Chinese medicine ischium pain-relieving decoction for treating sciatica | |
| CN100406043C (en) | A Chinese medicinal composition for treating prostatitis | |
| CN104013704A (en) | Pharmaceutical composition for treating chronic pelvic inflammatory disease and preparation method of composition | |
| CN103330793B (en) | Traditional Chinese medicine enema for treating chronic pelvic inflammatory disease | |
| CN102772575A (en) | Traditional Chinese medicine composition for treating chronic hepatitis B | |
| CN102698126B (en) | Traditional Chinese medicine compound having effect of treating prostatitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20111102 |